title: Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: a last chance or futile efforts?
authors.affiliation: UNSW Department of Surgery, Cancer Care Centre, St George Hospital, Kogarah, Sydney, New South Wales, Australia.
authors.forename: Terence C
authors.initials: TC
authors.lastname: Chua
authors.forename: Gregory
authors.initials: G
authors.lastname: Robertson
authors.forename: Winston
authors.initials: W
authors.lastname: Liauw
authors.forename: David L
authors.initials: DL
authors.lastname: Morris
mesh_terms: D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000601:surgery*; D010534:Peritoneal Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D012189:Retrospective Studies; D016879:Salvage Therapy / Q000009:adverse effects; D016019:Survival Analysis